HDL cholesterol as an associate of prevalent coronary artery disease in heterozygous Familial hypercholesterolemia beyond LDL cholesterol
Endocrine · 2025
DOI: 10.1007/s12020-025-04427-0 ↗Kurz gefasst
Fachartikel in der Zeitschrift Endocrine, 2025. Verfasst von Christos V Rizos und 34 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Medical School, University of Ioannina, Ioannina, Greece. Hauptthemen laut MEDLINE: Coronary Artery Disease, Hyperlipoproteinemia Type II, Cholesterol, HDL, Cholesterol, LDL. Die Arbeit nennt 39 Literaturangaben. Gefördert von: This study is funded by the Hellenic Atherosclerosis Society.
Abstract (Originalsprache)
PURPOSE: Low high-density lipoprotein cholesterol (HDL-C) levels have been associated with increased risk of coronary artery disease (CAD) in the general population. We examined the association between HDL-C levels and CAD prevalence in adult patients with heterozygous familial hypercholesterolemia (HeFH) in the HELLAS-FH registry. METHODS: Adult patients with HeFH were categorized into quartiles based on baseline (i.e., before any treatment) HDL-C levels. Patient demographics, lipid profile, CAD risk factors and CAD prevalence were analyzed. RESULTS: Patients (n = 1867; 960 males; mean age 51 ± 14 years) were divided into quartiles based on baseline HDL-C levels: Q1 (35 ± 5 mg/dL), Q2 (45 ± 2 mg/dL), Q3 (54 ± 3 mg/dL) and Q4 (70 ± 10 mg/dL). Lower HDL-C quartiles were associated with increased prevalence of CAD risk factors i.e. hypertension, type 2 diabetes (T2D), smoking and body mass index ≥ 25 kg/m2 compared with higher ones. The lowest HDL-C quartile was associated with the highest prevalence of established total (47.6%) and premature CAD (39.7%) among HeFH patients (p < 0.01 compared with all other quartiles). Multivariate logistic regression indicated 5% lower odds of prevalent CAD for each 1 mg/dL higher HDL-C after adjusting for major ASCVD risk factors, including triglycerides. This association of HDL-C was linear and persisted across patient subgroups based on sex, age, hypertension, smoking and T2D as well as across low-density lipoprotein cholesterol quartiles. CONCLUSION: An independent inverse linear association was observed between HDL-C concentrations and CAD prevalence in patients with HeFH. These findings emphasize the importance of considering HDL-C levels in CAD risk stratification of patients with HeFH.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Medical School, University of Ioannina, Ioannina, Greece.
- Cardiometabolic Center, LA apheresis Unit, Lipid Clinic, Metropolitan Hospital, Athens, Greece.
- 1st Cardiology Department, Athens Medical School, Lipids' Clinic, National and Kapodistrian University of Athens, Hippokration General Hospital, Athens, Greece.
- Department of Cardiology, Medical School, National and Kapodistrian University of Athens, Attikon University General Hospital, Athens, Greece.
- Second Department of Pediatrics, Medical School, National and Kapodistrian University of Athens, General Children's Hospital "P. & A. Kyriakou", Athens, Greece.
- Department of Internal Medicine, 424 General Military Training Hospital, Thessaloniki, Greece.
Förderung
- This study is funded by the Hellenic Atherosclerosis Society
Zitieren
APA
Rizos, C. V., Kolovou, G., Kolovou, V., Liamis, G., Skoumas, I., Rallidis, L., Garoufi, A., Sfikas, G., Penopoulos, A., Skalidis, E., Stamatelopoulos, K., Kotsis, V., Doumas, M., Lambadiari, V., Anagnostis, P., Mavrokefalou, E., Boufidou, A., Giannakopoulou, V., Anastasiou, G., …, & Liberopoulos, E. (2025). HDL cholesterol as an associate of prevalent coronary artery disease in heterozygous Familial hypercholesterolemia beyond LDL cholesterol. Endocrine. https://doi.org/10.1007/s12020-025-04427-0
Vancouver
Rizos CV, Kolovou G, Kolovou V, Liamis G, Skoumas I, Rallidis L, et al. HDL cholesterol as an associate of prevalent coronary artery disease in heterozygous Familial hypercholesterolemia beyond LDL cholesterol. Endocrine. 2025. doi:10.1007/s12020-025-04427-0
BibTeX
@article{Rizos2025,
author = {Rizos, Christos V and Kolovou, Genovefa and Kolovou, Vana and Liamis, George and Skoumas, Ioannis and Rallidis, Loukianos and Garoufi, Anastasia and Sfikas, George and Penopoulos, Athanasios and Skalidis, Emmanouil and Stamatelopoulos, Kimon and Kotsis, Vasileios and Doumas, Michalis and Lambadiari, Vaia and Anagnostis, Panagiotis and Mavrokefalou, Evgenia and Boufidou, Amalia and Giannakopoulou, Vasiliki and Anastasiou, Georgia and Petkou, Ermioni and Vlachopoulos, Charalambos and Dima, Ioanna and Georgios, Fakas and Papathanasiou, Konstantinos A and Attilakos, Achilleas and Koumaras, Charalambos and Agapakis, Dimitrios and Zacharis, Evangelos and Moustou, Chrysoula and Antza, Christina and Boutari, Chrysoula and Kountouri, Aikaterini and Mpellou, Eleni and Prodromiadou, Elisavet and Liberopoulos, Evangelos},
title = {HDL cholesterol as an associate of prevalent coronary artery disease in heterozygous Familial hypercholesterolemia beyond LDL cholesterol},
journal = {Endocrine},
year = {2025},
doi = {10.1007/s12020-025-04427-0}
}
EUVIMED